BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25297070)

  • 1. Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data.
    Oesper L; Satas G; Raphael BJ
    Bioinformatics; 2014 Dec; 30(24):3532-40. PubMed ID: 25297070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data.
    Oesper L; Mahmoody A; Raphael BJ
    Genome Biol; 2013 Jul; 14(7):R80. PubMed ID: 23895164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data.
    Yu Z; Li A; Wang M
    BMC Bioinformatics; 2016 Aug; 17():310. PubMed ID: 27538789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.
    Favero F; Joshi T; Marquard AM; Birkbak NJ; Krzystanek M; Li Q; Szallasi Z; Eklund AC
    Ann Oncol; 2015 Jan; 26(1):64-70. PubMed ID: 25319062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MixClone: a mixture model for inferring tumor subclonal populations.
    Li Y; Xie X
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25707430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AbsCN-seq: a statistical method to estimate tumor purity, ploidy and absolute copy numbers from next-generation sequencing data.
    Bao L; Pu M; Messer K
    Bioinformatics; 2014 Apr; 30(8):1056-1063. PubMed ID: 24389661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.
    Hibsh D; Buetow KH; Yaari G; Efroni S
    Nucleic Acids Res; 2016 May; 44(9):e81. PubMed ID: 26809676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurity: accurate tumor purity and ploidy inference from tumor-normal WGS data by jointly modelling somatic copy number alterations and heterozygous germline single-nucleotide-variants.
    Luo Z; Fan X; Su Y; Huang YS
    Bioinformatics; 2018 Jun; 34(12):2004-2011. PubMed ID: 29385401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer whole-genome sequencing: present and future.
    Nakagawa H; Wardell CP; Furuta M; Taniguchi H; Fujimoto A
    Oncogene; 2015 Dec; 34(49):5943-50. PubMed ID: 25823020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data.
    Chen M; Gunel M; Zhao H
    PLoS One; 2013; 8(11):e78143. PubMed ID: 24265680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
    Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
    BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shimmer: detection of genetic alterations in tumors using next-generation sequence data.
    Hansen NF; Gartner JJ; Mei L; Samuels Y; Mullikin JC
    Bioinformatics; 2013 Jun; 29(12):1498-503. PubMed ID: 23620360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
    Alkodsi A; Louhimo R; Hautaniemi S
    Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.
    Shen R; Seshan VE
    Nucleic Acids Res; 2016 Sep; 44(16):e131. PubMed ID: 27270079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
    Yu Z; Li A; Wang M
    BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous reference types can confound the detection of somatic mutation in solid cancers.
    Chen X; Zou X; Zhong W; Peng K; Wang D; Fan W; Lin J; Peng J
    DNA Repair (Amst); 2018 Sep; 69():6-13. PubMed ID: 30029072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.
    Zhang Z; Hao K
    PLoS Comput Biol; 2015 Nov; 11(11):e1004618. PubMed ID: 26583378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
    Abécassis J; Hamy AS; Laurent C; Sadacca B; Bonsang-Kitzis H; Reyal F; Vert JP
    PLoS One; 2019; 14(11):e0224143. PubMed ID: 31697689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonality Inference from Single Tumor Samples Using Low-Coverage Sequence Data.
    Donmez N; Malikic S; Wyatt AW; Gleave ME; Collins CC; Sahinalp SC
    J Comput Biol; 2017 Jun; 24(6):515-523. PubMed ID: 28056180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.